SCHEMBL3136352

SCHEMBL3136352

NC(=O)C1=NC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31104741 0.77
SCHEMBL5344297 0.75 CHRM3 (0.37)
SCHEMBL1755914 0.74
SCHEMBL17060813 0.67
SCHEMBL17793851 0.65 NNMT (0.30)
SCHEMBL8606606 0.64
SCHEMBL19886828 0.64
SCHEMBL13822799 0.64
SCHEMBL21900336 0.63
SCHEMBL19223279 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104903327-B For treating the pyrido-as autotaxin inhibitor or the pyrrolo--fused pyrimidine derivative of pain 伊莱利利公司 2016-09-07 CN disclosed
EP-2627655-A2 THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS Dart NeuroScience (Cayman) Ltd (KY) 2013-08-21 EP disclosed
WO-2012051213-A2 THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS HELICON THERAPEUTICS, INC. (US) 2012-04-19 WO disclosed
US-7642344-B2 Methods and compositions for determining the sequence of nucleic acid molecules OPERON BIOTECHNOLOGIES, INC. (US) 2010-01-05 US disclosed
EP-0962537-B1 Methods for analyzing nucleic acid molecules utilizing sizing techniques OPERON BIOTECHNOLOGIES INC (US) 2009-06-17 EP disclosed
EP-0992511-B1 Methods and compositions for determining the sequence of nucleic acid molecules OPERON BIOTECHNOLOGIES INC (US) 2009-03-11 EP disclosed
US-20080009613-A1 Methods and compositions for determining the sequence of nucleic acid molecules OPERON BIOTECHNOLOGIES, INC. (US) 2008-01-10 US disclosed
US-7247434-B2 Methods and compositions for determining the sequence of nucleic acid molecules OPERON BIOTECHNOLOGIES, INC. (US) 2007-07-24 US disclosed
EP-0868535-B9 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES QIAGEN GENOMICS INC (US) 2007-05-09 EP disclosed
US-7052846-B2 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques OPERON BIOTECHNOLOGIES, INC. (US) 2006-05-30 US disclosed
EP-0962537-A2 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques Rapigene, Inc. (US) 1999-12-08 EP disclosed
WO-1999005319-A9 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE INC (US) 1999-06-17 WO disclosed
WO-1999005319-A2 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE, INC. (US) 1999-02-04 WO disclosed
EP-0868535-A2 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES Rapigene, Inc. (US) 1998-10-07 EP disclosed
EP-0850320-A2 METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL DARWIN MOLECULAR CORPORATION (US) 1998-07-01 EP disclosed
EP-0840804-A1 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID MOLECULES UTILIZING SIZING TECHNIQUES DARWIN MOLECULAR CORPORATION (US) 1998-05-13 EP disclosed
WO-1997027331-A9 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES 1997-10-09 WO disclosed
WO-1997027331-A2 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES RAPIGENE, INC. (US) 1997-07-31 WO disclosed
WO-1997027327-A2 METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL RAPIGENE, INC. (US) 1997-07-31 WO disclosed
WO-1997027325-A2 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID MOLECULES UTILIZING SIZING TECHNIQUES RAPIGENE, INC. (US) 1997-07-31 WO disclosed